US 10822422
Antibodies against TL1a and uses thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 10822422 (Antibodies against TL1a and uses thereof) held by TEVA PHARMACEUTICALS AUSTRALIA PTY LTD expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
- Grant date
- Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/04